An Appropriate Use of Accelerated Approval - Aducanumab for Alzheimer's Disease.
作者信息
Dunn Billy, Stein Peter, Temple Robert, Cavazzoni Patrizia
机构信息
U.S. Food and Drug Administration, Silver Spring, MD.
出版信息
N Engl J Med. 2021 Aug 26;385(9):856-857. doi: 10.1056/NEJMc2111960. Epub 2021 Jul 28.
PMID:34320283
Abstract
摘要
Zotero 插件